Fosamprenavir Versus Other Protease Inhibitors

Clinical trial NCT00094523 · COMPLETED

Trial details

NCT number: NCT00094523
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus I

Start date: 2004-12-14
Primary completion: 2007-06-29
Enrollment: 314

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.